Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

BACKGROUND: Thrombotic thrombocytopenic purpura is a potentially life-threatening condition. Although the introduction of therapeutic plasma exchange has reduced mortality rates from over 90% to 10%-20%, approximately 40% of patients relapse, and outcomes may be fatal in refractory patients. There i...

Descripción completa

Detalles Bibliográficos
Autores principales: Öngören, Seniz, Salihoğlu, Ayşe, Apaydın, Tuğçe, Sadri, Sevil, Eşkazan, Ahmet Emre, Ar, Muhlis Cem, Elverdi, Tuğrul, Başlar, Zafer, Aydın, Yıldız, Soysal, Teoman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251381/
https://www.ncbi.nlm.nih.gov/pubmed/29966997
http://dx.doi.org/10.4274/balkanmedj.2017.1215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251381/
https://www.ncbi.nlm.nih.gov/pubmed/29966997
http://dx.doi.org/10.4274/balkanmedj.2017.1215

Ejemplares similares